Prestige Consumer Healthcare
PBH
#4654
Rank
HK$18.11 B
Marketcap
HK$382.48
Share price
-0.49%
Change (1 day)
-36.23%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): HK$30.79

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$30.89. In 2025 the company made an earnings per share (EPS) of HK$29.87 a decrease over its 2024 EPS that were of HK$33.72.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$30.793.06%
2025HK$29.87-11.4%
2024HK$33.72-367.08%
2023-HK$12.62-138.33%
2022HK$32.9311.7%
2021HK$29.4813.6%
2020HK$25.95-651.67%
2019-HK$4.70-148.78%
2018HK$9.64-83.29%
2017HK$57.71437.23%
2016HK$10.74-34.13%
2015HK$16.3152.94%
2014HK$10.66-8.11%
2013HK$11.60
2011HK$6.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.49 121.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$54.81 77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.04 78.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.29-8.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$48.46 56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$18.11-41.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.47-1.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$232.25-851.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.57-69.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel